![Abbvie Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png?tr=w-200)
Abbvie Inc
NYSE:ABBV
![Abbvie Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
137.6
185.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png)
Intrinsic Value
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. [ Read More ]
The intrinsic value of one
ABBV
stock under the Base Case scenario is
146.07
USD.
Compared to the current market price of 185.5 USD,
Abbvie Inc
is
Overvalued by 21%.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png?tr=w-200)
Valuation Backtest
Abbvie Inc
Run backtest to discover the historical profit from buying and selling
ABBV
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Abbvie Inc
Current Assets | 38.9B |
Cash & Short-Term Investments | 18.1B |
Receivables | 11.9B |
Other Current Assets | 8.9B |
Non-Current Assets | 110B |
Long-Term Investments | 305m |
PP&E | 5B |
Intangibles | 95.7B |
Other Non-Current Assets | 9.1B |
Current Liabilities | 41.5B |
Accounts Payable | 31.3B |
Short-Term Debt | 3m |
Other Current Liabilities | 10.2B |
Non-Current Liabilities | 99.3B |
Long-Term Debt | 63.8B |
Other Non-Current Liabilities | 35.5B |
Earnings Waterfall
Abbvie Inc
Revenue
|
54.4B
USD
|
Cost of Revenue
|
-18.3B
USD
|
Gross Profit
|
36.1B
USD
|
Operating Expenses
|
-20.1B
USD
|
Operating Income
|
16B
USD
|
Other Expenses
|
-10B
USD
|
Net Income
|
6B
USD
|
Free Cash Flow Analysis
Abbvie Inc
USD | |
Free Cash Flow | USD |
ABBV Profitability Score
Profitability Due Diligence
Abbvie Inc's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png)
Score
Abbvie Inc's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
ABBV Solvency Score
Solvency Due Diligence
Abbvie Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png)
Score
Abbvie Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for
ABBV
is 189.81 USD
with a low forecast of 171.7 USD and a high forecast of 224.7 USD.
Ownership
ABBV Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Price Appreciation
ABBV Price
Abbvie Inc
Average Annual Return | 29.67% |
Standard Deviation of Annual Returns | 6.1% |
Max Drawdown | -6% |
Market Capitalization | 327.5B USD |
Shares Outstanding | 1 765 869 952 |
Percentage of Shares Shorted | 0.92% |
ABBV News
Last Important Events
Abbvie Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Abbvie Inc
Company Profile
![Abbvie Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png?tr=w-200)
![Abbvie Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png?tr=w-200)
Country
Industry
Market Cap
Dividend Yield
Description
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 50,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The firm's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.
Contact
IPO
Employees
Officers
The intrinsic value of one
ABBV
stock under the Base Case scenario is
146.07
USD.
Compared to the current market price of 185.5 USD,
Abbvie Inc
is
Overvalued by 21%.